IBO
Impact BioMedical, Inc.
AMEX: IBO · HEALTHCARE · BIOTECHNOLOGY
$0.66
-2.59% today
Updated 2026-05-01
Market cap
$71.16M
P/E ratio
—
P/S ratio
2,223.81x
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$0 – $2
Volume
5.4M
Impact BioMedical, Inc. (IBO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-16,543.00%
ROE
-104.20%
ROA
-14.20%
Debt/equity
-1.94x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-408289.00 | — | — | — |
| 2018 | — | $-98109.00 | — | — | — |
| 2019 | $0.00 | $-590080.00 | — | — | — |
| 2020 | — | $-760069.00 | — | — | — |
| 2021 | $50000.00 | $-3.87M | — | -7,666.13% | -7,734.43% |
| 2022 | $50000.00 | $-7.05M | 100.00% | -6,808.00% | -14,102.00% |
| 2023 | $1.03M | $-4.34M | 100.00% | -391.07% | -420.98% |
| 2024 | $2.33M | $-2.05M | 100.00% | 23.67% | -88.01% |
| 2025 | $32000.00 | $-11.84M | -4,803.13% | -13,343.75% | -36,993.75% |